This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Venus Concept's (VERO) Latest Supply Deal to Aid its Business
by Zacks Equity Research
Venus Concept (VERO) announces an exclusive strategic supply arrangement with Skin Laundry Holdings, Inc.
B2Gold (BTG) Provides Upbeat Assessment Results for Gramolate
by Zacks Equity Research
B2Gold (BTG) announces the latest preliminary economic assessment results for the Gramalote project indicating an average yearly production of 185,000 ounces of gold over a 12.5-year life.
Universal Stainless (USAP) Rallies 78% in 6 Months: Here's Why
by Zacks Equity Research
Solid first-quarter performance on the back of the strength in aerospace contributes to the rally in Universal Stainless' (USAP) shares.
BrainsWay (BWAY) Inks Distribution Agreement to Expand Foothold
by Zacks Equity Research
BrainsWay's (BWAY) latest exclusive multi-year distribution agreement is likely to provide improved patient care in Canada.
Green Plains (GPRE) Updates on Nebraska Carbon Capture Project
by Zacks Equity Research
Green Plains (GPRE) enters into construction agreements and funding arrangements to facilitate the ordering of carbon sequestration equipment.
Lantheus (LNTH) Gains 33.3% YTD: What's Driving the Stock?
by Zacks Equity Research
Lantheus' (LNTH) focus on pipeline development raises optimism about the stock.
Energy Fuels (UUUU) Appoints Director to Grow REE Business
by Zacks Equity Research
Energy Fuels (UUUU) appoints Debra Bennethum as the director to grow its rare earth business. It also achieves the commercial production of separated REE at its White Mesa Mill.
Merit Medical (MMSI) Recalls Syringes Made by Jiangsu Shenli
by Zacks Equity Research
Merit Medical (MMSI) recalls certain products containing syringes made by a Chinese manufacturer, Jiangsu Shenli.
U.S. Steel (X) Issues Q2 View, Progresses on Nippon Transaction
by Zacks Equity Research
U.S. Steel (X) anticipates sequentially lower earnings for Q2 and projects EBITDA of $425 million. It continues to advance toward finalizing the Nippon Steel transaction.
Steel Dynamics (STLD) Sees Q2 Earnings to Fall on Lower Pricing
by Zacks Equity Research
Steel Dynamics (STLD) projects second-quarter earnings to decline sequentially, with mixed performance across steel, recycling and fabrication operations.
Are Basic Materials Stocks Lagging DRDGOLD Limited (DRD) This Year?
by Zacks Equity Research
Here is how DRDGOLD (DRD) and Ecolab (ECL) have performed compared to their sector so far this year.
Nutrien (NTR) Prices $1 Billion of 3-Year & 10-Year Senior Notes
by Zacks Equity Research
The senior notes will be unsecured and will rank on an equal footing with Nutrien's (NTR) current senior unsecured debt.
LyondellBasell (LYB) Boosts PP Compounding Production in China
by Zacks Equity Research
The start-up of the new production line marks another milestone in LyondellBasell's (LYB) ongoing commitment to the China market.
GE HealthCare's (GEHC) New Tie-Up to Boost Patient Care in Mexico
by Zacks Equity Research
GE HealthCare's (GEHC) latest agreement is likely to standardize care protocols and improve the quality of CT, MR and ultrasound examinations.
Nucor (NUE) Projects Lower Q2 Earnings Amid Weaker Steel Prices
by Zacks Equity Research
Nucor (NUE) expects second-quarter earnings to decline sequentially and has returned over $1.76 billion to stockholders so far in 2024.
Cencora (COR) Gains 13.2% YTD: What's Driving the Stock?
by Zacks Equity Research
Cencora (COR) gaining traction from the robust U.S. Healthcare Solutions segment raises optimism about the stock.
DOW Launches Two New REVOLOOP Recycled Plastics Resins
by Zacks Equity Research
DOW plans to transform waste and commercialize 3 million metric tons of circular and green solutions per year by 2030.
Allurion (ALUR) Unveils Positive Data for Its Balloon Therapy
by Zacks Equity Research
Allurion (ALUR) announces positive weight loss data for its gastric balloon technology.
Smith & Nephew's (SNN) CORIOGRAPH to Aid Arthroplasty Procedure
by Zacks Equity Research
Smith & Nephew (SNN) announces the launch of its new CORIOGRAPH Pre-Operative Planning and Modeling Services, exclusively for use with the CORI Surgical System.
3 Reasons to Hold Veeva Systems (VEEV) Stock in Your Portfolio
by Zacks Equity Research
Veeva Systems' (VEEV) strong product portfolio raises optimism about the stock.
Element Solutions (ESI) Scales 52-week High: What's Driving It?
by Zacks Equity Research
Element Solutions (ESI) revises its 2024 guidance upward, driven by strong electronics business performance, leading to the stock price rally.
Huntsman (HUN) Unveils New Innovation Center in Belgium
by Zacks Equity Research
The new 11,000-square-meter facility by Huntsman (HUN) includes a world-scale analytical laboratory, two machine halls and fully equipped and automated product testing areas.
Patterson Companies' (PDCO) Launch to Boost Insurance Workflow
by Zacks Equity Research
Patterson Companies' (PDCO) latest offering is likely to offer customers additional options for their electronic insurance processing and patient billing statement workflow.
HealthEquity (HQY) Gains 25.3% YTD: What's Driving the Rally?
by Zacks Equity Research
HealthEquity's (HQY) sustained strength in HSAs raises optimism about the stock.
Accuray's (ARAY) Precision TPS Gets Approved by China's NMPA
by Zacks Equity Research
Accuray (ARAY) announces the approval of the Accuray Precision Treatment Planning System by the Chinese Medical Products Administration.